ALLMedicine™ Transjugular Liver Biopsy Center
Research & Reviews 71 results
https://clinicaltrials.gov/ct2/show/NCT03520660
Mar 23rd, 2023 - Study Description:
https://doi.org/10.1016/j.hpb.2023.02.006
HPB : the Official Journal of the International Hepato Pa... Zhang H, Wang Z et. al.
Mar 7th, 2023 - Hepatic venous pressure gradient (HVPG) is the criterion for assessing sinusoidal portal hypertension. Using HVPG to assess the degree of liver fibrosis by transjugular liver biopsy (TJLB) is still being explored, as no data has been shown that po...
https://doi.org/10.1016/j.clinimag.2023.02.004
Clinical Imaging; Vu T, Eberly H et. al.
Feb 22nd, 2023 - To demonstrate that patients with pre-cirrhotic bridging fibrosis (Meta-analysis of Histological Data in Viral Hepatitis, METAVIR stage F3) and clinically significant portal hypertension (CSPH, Hepatic Venous Pressure Gradient ≥10 mmHg) experience...
https://doi.org/10.1097/LVT.0000000000000079
Liver Transplantation : Official Publication of the Ameri... Shingina A, Chadha R et. al.
Feb 7th, 2023 - We conducted a web-based survey to characterize liver transplant (LT) evaluation and listing practices for patients being evaluated for CHLT, with a specific emphasis on patients with CHD, around transplant centers in North America. Very few proto...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372801
World Journal of Gastroenterology; Rangwani S, Ardeshna DR et. al.
Sep 27th, 2022 - Endoscopic ultrasound guided liver biopsy (EUS-LB) has emerged as a minimally-invasive alternative to the traditional (percutaneous or transjugular) liver biopsy techniques for the diagnosis of liver parenchymal diseases. Po-tentially, EUS-LB comb...
Clinicaltrials.gov 11 results
https://clinicaltrials.gov/ct2/show/NCT03520660
Mar 23rd, 2023 - Study Description:
https://clinicaltrials.gov/ct2/show/NCT03408171
Apr 14th, 2020 - Chronic liver disorders (CLD) are a major cause of morbidity and mortality for individuals in the US. Though serologic analysis will often lead to a conclusive diagnosis, liver biopsy remains an important method for helping to determine the etiolo...
https://clinicaltrials.gov/ct2/show/NCT01644656
Sep 6th, 2018 - DESIGN The study is designed as a prospective, cross-sectional, diagnostic study in which the investigators will evaluate the use of ARFI to diagnose clinically significant portal hypertension (CSPH defined as hepatic veous pressure gradient (HVPG...
https://clinicaltrials.gov/ct2/show/NCT02788240
Feb 6th, 2018 - All consecutive ACLF (Acute on Chronic Liver failure) patients presenting to the institute of liver and biliary sciences, irrespective of the etiology , who have survived the acute phase (i.e. 90 days of onset of the acute on chronic liver failure...
https://clinicaltrials.gov/ct2/show/NCT02311348
Jul 2nd, 2017 - Millions of Americans are diagnosed with some form of Hepatitis or other liver disease requiring treatment. Liver biopsies are frequently performed mainly to stage disease, aid in diagnosis and to guide treatment. As part of the assessment of Hepa...
News 2 results
https://www.onclive.com/view/advanced-systemic-mastocytosis-expert-insight-into-epidemiology-diagnosis-and-treatment
Sep 15th, 2021 - SYSTEMIC MASTOCYTOSIS (SM) is a rare disease that often first presents on the skin. It is characterized by the overaccumulation of mast cells (MCs), which can then penetrate such internal organs as bone marrow (BM).¹ Challenges in identification a...
https://www.onclive.com/view/case-2-46-year-old-woman-with-sm
Aug 19th, 2021 - Dan DeAngelo, MD, PhD: Let me bring on a second case. She’s a wonderful woman. Ashley was referred about 15 or 16 years ago to me because she was in hospice care, believe it or not. She was being managed locally. She was having chronic diarrhea, w...